Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yale H Caplan

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Analytical Toxicology|April 18, 2009
Multiple drug ingestion by ecstasy abusers in the United StatesDavid L Black, Beverly Cawthon, Tim Robert, et al.
Journal of Analytical Toxicology|May 9, 2015
Concerning the Sixth Edition of Garriott's Medicolegal Aspects of AlcoholYale H Caplan, Bruce A Goldberger, Roger L Bertholf, et al.
Journal of Analytical Toxicology|January 24, 2009
Normalization of urinary drug concentrations with specific gravity and creatinineEdward J Cone, Yale H Caplan, Frank Moser, et al.
Journal of Analytical Toxicology|September 14, 2014
Determining zolpidem compliance: urinary metabolite detection and prevalence in chronic pain patientsDavid M Schwope, Anne DePriest, David L Black, et al.
Journal of Analytical Toxicology|November 7, 2012
Urine drug testing of chronic pain patients. V. Prevalence of propoxyphene following its withdrawal from the United States marketBrandi Puet, Anne DePriest, Julie Knight, et al.
Forensic Science International|December 29, 2009
Urine testing for norcodeine, norhydrocodone, and noroxycodone facilitates interpretation and reduces false negativesEdward J Cone, Anne Zichterman, Rebecca Heltsley, et al.
Journal of Analytical Toxicology|August 9, 2011
Urine drug testing of chronic pain patients. III. Normetabolites as biomarkers of synthetic opioid useAnne Depriest, Rebecca Heltsley, David L Black, et al.
Journal of Analytical Toxicology|January 30, 2010
Urine drug testing of chronic pain patients. II. Prevalence patterns of prescription opiates and metabolitesRebecca Heltsley, Anne Zichterman, David L Black, et al.
Journal of Analytical Toxicology|June 11, 2004
Oxycodone involvement in drug abuse deaths. II. Evidence for toxic multiple drug-drug interactionsEdward J Cone, Reginald V Fant, Jeffrey M Rohay, et al.
Journal of Analytical Toxicology|October 19, 2011
Oral fluid drug testing of chronic pain patients. I. Positive prevalence rates of licit and illicit drugsRebecca Heltsley, Anne DePriest, David L Black, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Analytical Toxicology|April 18, 2009
Multiple drug ingestion by ecstasy abusers in the United StatesDavid L Black, Beverly Cawthon, Tim Robert, et al.
Journal of Analytical Toxicology|May 9, 2015
Concerning the Sixth Edition of Garriott's Medicolegal Aspects of AlcoholYale H Caplan, Bruce A Goldberger, Roger L Bertholf, et al.
Journal of Analytical Toxicology|January 24, 2009
Normalization of urinary drug concentrations with specific gravity and creatinineEdward J Cone, Yale H Caplan, Frank Moser, et al.
Journal of Analytical Toxicology|September 14, 2014
Determining zolpidem compliance: urinary metabolite detection and prevalence in chronic pain patientsDavid M Schwope, Anne DePriest, David L Black, et al.
Journal of Analytical Toxicology|November 7, 2012
Urine drug testing of chronic pain patients. V. Prevalence of propoxyphene following its withdrawal from the United States marketBrandi Puet, Anne DePriest, Julie Knight, et al.
Forensic Science International|December 29, 2009
Urine testing for norcodeine, norhydrocodone, and noroxycodone facilitates interpretation and reduces false negativesEdward J Cone, Anne Zichterman, Rebecca Heltsley, et al.
Journal of Analytical Toxicology|August 9, 2011
Urine drug testing of chronic pain patients. III. Normetabolites as biomarkers of synthetic opioid useAnne Depriest, Rebecca Heltsley, David L Black, et al.
Journal of Analytical Toxicology|January 30, 2010
Urine drug testing of chronic pain patients. II. Prevalence patterns of prescription opiates and metabolitesRebecca Heltsley, Anne Zichterman, David L Black, et al.
Journal of Analytical Toxicology|June 11, 2004
Oxycodone involvement in drug abuse deaths. II. Evidence for toxic multiple drug-drug interactionsEdward J Cone, Reginald V Fant, Jeffrey M Rohay, et al.
Journal of Analytical Toxicology|October 19, 2011
Oral fluid drug testing of chronic pain patients. I. Positive prevalence rates of licit and illicit drugsRebecca Heltsley, Anne DePriest, David L Black, et al.
Pageof 3